SCHEMBL6068060

SCHEMBL6068060

CCNC(=O)Nc1nc2ccc(C(=O)CCNC(=O)c3ccc(F)cc3)cc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
ABL1 P00519 7/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
MEN1 O00255 1/20 0.53
SCD O00767 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
LCK P06239 2/20 0.51
LRRK2 Q5S007 2/20 0.50
PIK3CD O00329 1/20 0.48
KDM4E B2RXH2 1/20 0.48
NFKB1 P19838 1/20 0.48
HTT P42858 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
GSK3B P49841 1/20 0.48
PDPK1 O15530 1/20 0.47
DYRK1A Q13627 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6067885 0.91 ABL1 (0.62) MAPTABL1NPC1RAB9ASCD
SCHEMBL6068071 0.90 ABL1 (0.49) POLBMAPTABL1NPC1RAB9A
SCHEMBL6068062 0.89 ABL1 (0.52) ABL1NPC1RAB9ASMN1; SMN2LCK
SCHEMBL6068048 0.84 NPC1 (0.56) POLBABL1NPC1RAB9AMEN1
SCHEMBL6068381 0.83 ABL1 (0.62) POLBMAPTABL1NPC1RAB9A
SCHEMBL6067969 0.82 ABL1 (0.64) ABL1NPC1RAB9ASMN1; SMN2LCK
SCHEMBL6067918 0.80 ABL1 (0.53) POLBMAPTABL1NPC1RAB9A
SCHEMBL6068142 0.79 GSK3B (0.67) ABL1NPC1RAB9ASMN1; SMN2LCK
SCHEMBL4746047 0.79 ABL1 (0.70) ABL1NPC1RAB9ASMN1; SMN2LCK
SCHEMBL6068149 0.78 ABL1 (0.60) ABL1NPC1RAB9ASMN1; SMN2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091227-B2 Benzothiazole derivatives ABBOTT GMBH & CO. KG (DE) 2006-08-15 US disclosed
US-20030153568-A1 Benzothiazole derivatives BASF AKTIENGESELLSCHAFT LUDWIGSHAFEN, GERMANY 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153568-A1 Benzothiazole derivatives TK1, FLT1, CDK1 POLB 1705/4885MAPT 1192/4885ABL1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.